Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Spry vs TeleZen MD

Spry
Graded #409

Lower grade

vs+3.4000000000000057
TeleZen MD
Graded #329

Higher grade

The verdict

TeleZen MD takes it — 60.2/100 to 56.8/100.

TeleZen MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleZen MD (telezenmd.com) is a 100% online U.S.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSpry +10
54
44
Dose & formulationEven
64
64
Clinical oversightTeleZen MD +31
55
86
Labs & monitoringTeleZen MD +1
52
53
FulfillmentTeleZen MD +1
61
62
Contract termsSpry +8
55
47
Spry · left barTeleZen MD · right bar

The numbers

MetricSpryTeleZen MD
WeighScore56.8/10060.2/100
GradeCC
Scorecard rank#409#329
Semaglutide$199/mo (starting dose, compounded)$198/mo (compounded)
Tirzepatide$299/mo (starting dose, compounded)$298/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Spry

Graded #409 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
TeleZen MD

Graded #329 · C

Strengths

  • Says it serves all 50 states — among the broadest claimed reach in the compounded segment
  • Markets U.S.-based, FDA-registered pharmacies
  • $100 off your first order with code WELCOME100
  • Fully online U.S. telehealth model with physician evaluation
  • Education-forward, physician-led positioning

Where it loses points

  • Partner pharmacy not named
  • Legal entity name and state of incorporation not disclosed
  • Brand-name medications not addressed on the homepage
  • LegitScript certification not confirmed
  • All-50-states claim is the provider's own, not independently verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard